DTS-201: Phase I data

In a Phase I trial in 25 patients, the maximum tolerated dose of DTS-201 was 400 mg/m 2 every 3 weeks. Nine patients with chemotherapy-resistant tumors had disease stabilization and 1 patient had a pa...